A股異動 | 藍帆醫療漲逾6% 輸美部分產品關税下降
格隆匯2月6日丨藍帆醫療(002382.SZ)現漲6.48%,報19.07元,暫成交4.38億元,最新總市值184億。公司昨日公告稱,近日,美國貿易代表辦公室陸續發佈了第三批2,000億美元加徵關税的豁免清單、第四批第一期3,000億美元的徵税清單。公司的丁腈手套產品位列上述清單範疇,對應公司的丁腈非醫療級手套產品將豁免加徵關税,關税税率由28%下降至3%;丁腈醫療級手套產品的關税税率由15%下降至7.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.